Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-29 @ 10:02 PM
Study NCT ID:
NCT01065558
Status:
COMPLETED
Last Update Posted:
2013-04-18
First Post:
2010-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
Sponsor:
Psyadon Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Ecopipam and Lesch-Nyhan
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None